leprosy
DESCRIPTION
LeprosyTRANSCRIPT
![Page 1: Leprosy](https://reader036.vdocument.in/reader036/viewer/2022062510/54b5b58e4a79596e0a8b45db/html5/thumbnails/1.jpg)
Leprosy (Hansen’s Disease)
Brought to you by
![Page 2: Leprosy](https://reader036.vdocument.in/reader036/viewer/2022062510/54b5b58e4a79596e0a8b45db/html5/thumbnails/2.jpg)
Leprosy is caused by Mycobacterium leprae
Scollard, DM et al. 2006. “The continuing challenges of leprosy.” Clinical microbiology reviews 19, no. 2: 338-81.
Brought to you by
![Page 3: Leprosy](https://reader036.vdocument.in/reader036/viewer/2022062510/54b5b58e4a79596e0a8b45db/html5/thumbnails/3.jpg)
Discovered by Gerhard Armauer Hansen in 1873
Global Project on the History of Leprosyhttp://www.leprosyhistory.org/graphics/gallery/hansen.jpg
Brought to you by
![Page 4: Leprosy](https://reader036.vdocument.in/reader036/viewer/2022062510/54b5b58e4a79596e0a8b45db/html5/thumbnails/4.jpg)
Bacteria Resides in Cooler Parts of the Body
http://www.nlm.nih.gov
SkinPeripheral
NervesBrought to you by
![Page 5: Leprosy](https://reader036.vdocument.in/reader036/viewer/2022062510/54b5b58e4a79596e0a8b45db/html5/thumbnails/5.jpg)
Symptoms & Diagnosis: (1) Skin Lesions
Worobec, Sophie M. 2009. “Treatment of leprosy/Hansen's disease in the early 21st century.” Dermatologic therapy 22,
no. 6: 518-37.
Brought to you by
![Page 6: Leprosy](https://reader036.vdocument.in/reader036/viewer/2022062510/54b5b58e4a79596e0a8b45db/html5/thumbnails/6.jpg)
Global Project on the History of Leprosyhttp://www.leprosyhistory.org/graphics/gallery/mleprae.jpg
Symptoms & Diagnosis: (2) Skin Smear Tests
Ziehl Neelsen Carbol Fuchsin Stain (ZNCF)
Brought to you by
![Page 7: Leprosy](https://reader036.vdocument.in/reader036/viewer/2022062510/54b5b58e4a79596e0a8b45db/html5/thumbnails/7.jpg)
Transmission
Nasal/oral Droplets
Dermal Inoculations
Brought to you by
![Page 8: Leprosy](https://reader036.vdocument.in/reader036/viewer/2022062510/54b5b58e4a79596e0a8b45db/html5/thumbnails/8.jpg)
Immunocompromised individuals are more
susceptible to disease
Brought to you by
![Page 9: Leprosy](https://reader036.vdocument.in/reader036/viewer/2022062510/54b5b58e4a79596e0a8b45db/html5/thumbnails/9.jpg)
Mechanism of Nerve Damage
Scollard, DM et al. 2006. “The continuing challenges of leprosy.” Clinical microbiology reviews 19, no. 2: 338-81.
1. Entry Through Blood Vessels
2. Inflammatory Response
3. DemyelinationBrought to you by
![Page 10: Leprosy](https://reader036.vdocument.in/reader036/viewer/2022062510/54b5b58e4a79596e0a8b45db/html5/thumbnails/10.jpg)
Sensory Loss
Paralysis
Deformities
Outcomes of Nerve Damage
Brought to you by
![Page 11: Leprosy](https://reader036.vdocument.in/reader036/viewer/2022062510/54b5b58e4a79596e0a8b45db/html5/thumbnails/11.jpg)
Sensory Loss Can Lead to Secondary Infections and Severe Deformities
Brought to you by
![Page 12: Leprosy](https://reader036.vdocument.in/reader036/viewer/2022062510/54b5b58e4a79596e0a8b45db/html5/thumbnails/12.jpg)
1941: Discovery of Dapsone
Targets dihydropteroate synthase (DHPS)
Inhibits nucleic acid synthesis
Brought to you by
![Page 13: Leprosy](https://reader036.vdocument.in/reader036/viewer/2022062510/54b5b58e4a79596e0a8b45db/html5/thumbnails/13.jpg)
1964: Dapsone Resistance from Missense Mutations in DHPS
Brought to you by
![Page 14: Leprosy](https://reader036.vdocument.in/reader036/viewer/2022062510/54b5b58e4a79596e0a8b45db/html5/thumbnails/14.jpg)
1960’s: Rifampicin and Clofazimine Discovered
Rifampicin (Rifampin): Inhibit RNA synthesis
Clofazimine: Anti-inflammatoryBrought to you by
![Page 15: Leprosy](https://reader036.vdocument.in/reader036/viewer/2022062510/54b5b58e4a79596e0a8b45db/html5/thumbnails/15.jpg)
1981: WHO Proposes Multi-Drug Therapy (MDT) Combination of DAPSONE,
RIFAMPICIN, and CLOFAZIMINE
+ +
Brought to you by
![Page 16: Leprosy](https://reader036.vdocument.in/reader036/viewer/2022062510/54b5b58e4a79596e0a8b45db/html5/thumbnails/16.jpg)
Brought to you by
![Page 17: Leprosy](https://reader036.vdocument.in/reader036/viewer/2022062510/54b5b58e4a79596e0a8b45db/html5/thumbnails/17.jpg)
1995: WHO Distributes MDT Drugs for Free to Worldwide Patients
Brought to you by
![Page 18: Leprosy](https://reader036.vdocument.in/reader036/viewer/2022062510/54b5b58e4a79596e0a8b45db/html5/thumbnails/18.jpg)
1999: Global Alliance to Eliminate Leprosy As a Public Health Problem
Brought to you by
![Page 19: Leprosy](https://reader036.vdocument.in/reader036/viewer/2022062510/54b5b58e4a79596e0a8b45db/html5/thumbnails/19.jpg)
Obstacles to Eliminating Leprosy in Endemic Countries
STIGMA
Brought to you by
![Page 20: Leprosy](https://reader036.vdocument.in/reader036/viewer/2022062510/54b5b58e4a79596e0a8b45db/html5/thumbnails/20.jpg)
Overcoming Stigma
Mass Media
Integrated Primary Health Services
Education & TrainingBrought to you by
![Page 21: Leprosy](https://reader036.vdocument.in/reader036/viewer/2022062510/54b5b58e4a79596e0a8b45db/html5/thumbnails/21.jpg)
Brought to you by
![Page 22: Leprosy](https://reader036.vdocument.in/reader036/viewer/2022062510/54b5b58e4a79596e0a8b45db/html5/thumbnails/22.jpg)
References1. Leprosy Today. “Leprosy: The Disease.” World Health Organization.
http://www.who.int/lep/leprosy/en/index.html (accessed February 25 2010).
2. Matsuoka, Masanori M. 2010. “Drug Resistance in Leprosy.” Japanese journal of infectious diseases 63, no. 1: 1-7. http://www.nih.go.jp.libproxy.lib.unc.edu (accessed February 25, 2010).
3. National Hansen’s Disease (Leprosy) Program. “Hansen’s Disease (Leprosy) Facts.” U.S. Department of Health and Human Services. http://www.hrsa.gov/hansens/ Accessed February 25 2010.
4. Scollard, DM, LB Adams, TP Gillis, JL Krahenbuhl , RW Truman, and DL Williams. 2006. “The continuing challenges of leprosy.” Clinical microbiology reviews 19, no. 2: 338-81. http://www.ncbi.nlm.nih.gov.libproxy.lib.unc.edu (accessed February 25, 2010).
5. Worobec, Sophie M. 2009. “Treatment of leprosy/Hansen's disease in the early 21st century.” Dermatologic therapy 22, no. 6: 518-37. http://www3.interscience.wiley.com.libproxy.lib.unc.edu (accessed February 25, 2010. Brought to you by
![Page 23: Leprosy](https://reader036.vdocument.in/reader036/viewer/2022062510/54b5b58e4a79596e0a8b45db/html5/thumbnails/23.jpg)
This platform has been started by Parveen Kumar Chadha with the vision that nobody should suffer the way he has suffered because of lack and improper healthcare facilities in India. We need lots of funds manpower etc. to make this vision a reality please contact us. Join us as a member for a noble cause.
Brought to you by
![Page 24: Leprosy](https://reader036.vdocument.in/reader036/viewer/2022062510/54b5b58e4a79596e0a8b45db/html5/thumbnails/24.jpg)
Our views have increased the mark of the 20,000
Thank you viewers
Looking forward for franchise,
collaboration, partners. Brought to you by
![Page 25: Leprosy](https://reader036.vdocument.in/reader036/viewer/2022062510/54b5b58e4a79596e0a8b45db/html5/thumbnails/25.jpg)
011-25464531 ,011-41425180 ,011-66217387
+91-9818308353+,91-9818569476
www.other-mother.in
https://www.facebook.com/pages/Other-Mother-Nursing-Crusade/224235031114989?ref=hl
http://www.linkedin.com/profile/view?id=326103341&trk=nav_responsive_tab_profile
https://twitter.com/othermotherindi
https://cparveen.wix.com/other-mother
A WORLDWIDE MISSITION
Contact Us-:
JOIN US
Saxbee Consultants Details :-www.parveenchadha.com
Brought to you by